ORCID as entered in ROS

Select Publications
2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310
,2022, 'Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103513
,2022, 'Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103572
,2022, 'Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?', Addiction, http://dx.doi.org/10.1111/add.16032
,2021, 'Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia', Drug and Alcohol Review, 40, pp. 1349 - 1353, http://dx.doi.org/10.1111/dar.13282
,2021, 'Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109050
,2021, 'Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy', Journal of Addiction Medicine, 15, pp. 525 - 526, http://dx.doi.org/10.1097/ADM.0000000000000788
,2021, 'The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study', Addiction, 116, pp. 3139 - 3152, http://dx.doi.org/10.1111/add.15514
,2021, 'Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109091
,2021, '535The epidemiology of all-cause and cause-specific mortality following release from prison in 11 countries', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.091
,2021, 'Mapping drug epidemiology futures', International Journal of Drug Policy, 94, http://dx.doi.org/10.1016/j.drugpo.2021.103378
,2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612
,2021, 'Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis', Addiction, 116, pp. 1664 - 1676, http://dx.doi.org/10.1111/add.15316
,2021, 'A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19', International Journal of Drug Policy, 92, http://dx.doi.org/10.1016/j.drugpo.2021.103127
,2021, 'All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis', Addiction, 116, pp. 725 - 742, http://dx.doi.org/10.1111/add.15239
,2021, 'Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis', Lancet Psychiatry, 8, pp. 301 - 309, http://dx.doi.org/10.1016/S2215-0366(20)30538-1
,2021, 'What predicts pharmacists’ engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy', International Journal of Clinical Pharmacy, 43, pp. 420 - 429, http://dx.doi.org/10.1007/s11096-020-01074-5
,2021, 'Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108464
,2021, 'The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas', Journal of Substance Abuse Treatment, 121, http://dx.doi.org/10.1016/j.jsat.2020.108189
,2021, 'Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia', Drug and Alcohol Review, 40, pp. 98 - 108, http://dx.doi.org/10.1111/dar.13144
,2021, 'Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001–2018: Findings from the OATS retrospective cohort study', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108354
,2020, 'Using Linked Data to Examine the Epidemiology of All-Cause and Cause-Specific Mortality Following Release from Incarceration in Eleven Countries', International Journal of Population Data Science, 5, http://dx.doi.org/10.23889/ijpds.v5i5.1478
,2020, 'Data Resource Profile: The Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia', International Journal of Epidemiology, 49, pp. 1774 - 1775G, http://dx.doi.org/10.1093/ije/dyaa125
,2020, 'Global opioid agonist treatment: a review of clinical practices by country', Addiction, 115, pp. 2243 - 2254, http://dx.doi.org/10.1111/add.15087
,2020, 'Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysis', Drug and Alcohol Dependence, 217, http://dx.doi.org/10.1016/j.drugalcdep.2020.108343
,2020, 'Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study', Research in Social and Administrative Pharmacy, 16, pp. 1694 - 1701, http://dx.doi.org/10.1016/j.sapharm.2020.02.009
,2020, 'Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia', Drug and Alcohol Dependence, 216, pp. 108267, http://dx.doi.org/10.1016/j.drugalcdep.2020.108267
,2020, 'Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis', International Journal of Drug Policy, 84, http://dx.doi.org/10.1016/j.drugpo.2020.102866
,2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941
,2020, 'Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis', Addiction, 115, pp. 1011 - 1023, http://dx.doi.org/10.1111/add.14892
,2020, 'All-Cause and Cause-Specific Mortality among People Using Extramedical Opioids: A Systematic Review and Meta-analysis', JAMA Psychiatry, 77, pp. 493 - 502, http://dx.doi.org/10.1001/jamapsychiatry.2019.4170
,2020, 'Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review', Drug and Alcohol Dependence, 209, http://dx.doi.org/10.1016/j.drugalcdep.2020.107899
,2020, 'Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2019.102656
,2020, 'Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis', Drug and Alcohol Dependence, 207, http://dx.doi.org/10.1016/j.drugalcdep.2019.107793
,2020, 'Frequency of injecting among people who inject drugs: A systematic review and meta-analysis', International Journal of Drug Policy, 76, http://dx.doi.org/10.1016/j.drugpo.2019.102619
,2020, 'The Mortality after Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis.', International Journal of Population Data Science, 5, pp. 1145, http://dx.doi.org/10.23889/ijpds.v5i1.1145
,2020, 'All-Cause and Overdose Mortality Risk among People Prescribed Opioids: A Systematic Review and Meta-analysis', Pain Medicine United States, 21, pp. 3700 - 3711, http://dx.doi.org/10.1093/PM/PNAA214
,2020, 'Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis', Lancet Global Health, 8, pp. e76 - e91, http://dx.doi.org/10.1016/S2214-109X(19)30462-0
,2020, 'Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada', American Journal of Public Health, 110, pp. 45 - 50, http://dx.doi.org/10.2105/AJPH.2019.305379
,2020, 'Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia', Drug and Alcohol Review, 39, pp. 83 - 92, http://dx.doi.org/10.1111/dar.13006
,2020, 'Frequency of injecting among people who inject drugs: A systematic review and meta-analysis.', Int J Drug Policy, 76, pp. 102619, http://dx.doi.org/10.1016/j.drugpo.2019.102619
,2019, 'Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling study', Journal of Viral Hepatitis, 26, pp. 1388 - 1403, http://dx.doi.org/10.1111/jvh.13187
,2019, 'The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis', International Journal of Drug Policy, 73, pp. 172 - 184, http://dx.doi.org/10.1016/j.drugpo.2019.07.030
,2019, 'Global patterns of opioid use and dependence: harms to populations, interventions, and future action', Lancet, 394, pp. 1560 - 1579, http://dx.doi.org/10.1016/S0140-6736(19)32229-9
,2019, 'Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis', Addiction, 114, pp. 1738 - 1750, http://dx.doi.org/10.1111/add.14706
,2019, 'Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia', Drug and Alcohol Review, 38, pp. 690 - 698, http://dx.doi.org/10.1111/dar.12976
,2019, 'Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis', International Journal of Drug Policy, 70, pp. 87 - 93, http://dx.doi.org/10.1016/j.drugpo.2019.05.005
,2019, 'Protocol for the Data-Linkage Alcohol Cohort Study (DACS): Investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2019-030605
,2019, 'The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study', Lancet Public Health, 4, pp. e334 - e342, http://dx.doi.org/10.1016/S2468-2667(19)30060-X
,2019, 'A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus among People Who Inject Drugs - Do Gender-Based Differences Vary by Country-Level Indicators?', Journal of Infectious Diseases, 220, pp. 78 - 90, http://dx.doi.org/10.1093/infdis/jiz058
,